Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@occams_tooth Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1858315561790545920.png) @occams_tooth Occam's Toothbrush

Occam's Toothbrush posts on X about $dnli, $beam, $arwr, $ions the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1858315561790545920/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1858315561790545920/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXX -XX%
- X Months XXXXXXX +310%
- X Year XXXXXXX +29,893%

### Mentions: X [#](/creator/twitter::1858315561790545920/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1858315561790545920/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XX%
- X Months XXX +69%
- X Year XXX +4,200%

### Followers: XXX [#](/creator/twitter::1858315561790545920/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1858315561790545920/c:line/m:followers.svg)

- X Week XXX +2.70%
- X Month XXX +8.30%
- X Months XXX +466%
- X Year XXX +2,365%

### CreatorRank: undefined [#](/creator/twitter::1858315561790545920/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1858315561790545920/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  [stocks](/list/stocks) 

**Social topic influence**
[$dnli](/topic/$dnli), [$beam](/topic/$beam) #33, [$arwr](/topic/$arwr), [$ions](/topic/$ions), [$150m](/topic/$150m), [$pfe](/topic/$pfe), [target](/topic/target), [$100mtarget](/topic/$100mtarget), [$regn](/topic/$regn), [$ptct](/topic/$ptct)

**Top accounts mentioned or mentioned by**
[@geneinvesting](/creator/undefined) [@zhaoweiasu](/creator/undefined) [@rnaianalyst](/creator/undefined) [@ttramyloid](/creator/undefined) [@avidresearch](/creator/undefined) [@bertrandbio](/creator/undefined) [@profoak](/creator/undefined) [@hall8jack](/creator/undefined) [@theeconomist](/creator/undefined) [@thebiohunter](/creator/undefined) [@jfais20](/creator/undefined) [@sanctuarybio](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@ldtimmerman](/creator/undefined) [@openai](/creator/undefined) [@zacharybrennan](/creator/undefined) [@jaredwhitlock](/creator/undefined) [@crocsanalyst](/creator/undefined) [@skathire](/creator/undefined) [@novartis](/creator/undefined)

**Top assets mentioned**
[Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) [BEAM (BEAM)](/topic/$beam) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Pfizer, Inc. (PFE)](/topic/$pfe) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [PTC Therapeutics, Inc. (PTCT)](/topic/$ptct) [Royalty Pharma plc Class A Ordinary Shares (RPRX)](/topic/$rprx) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp)
### Top Social Posts
Top posts by engagements in the last XX hours

"Tragic that $DNLI may have blundered a chance for a PRV with tivi approval. PRV sale would be over half what theyre getting in this royalty deal. $DNLI"  
[X Link](https://x.com/occams_tooth/status/1996754362107154527)  2025-12-05T01:31Z XXX followers, XXX engagements


"Arrowhead $ARWR stock move is logical but timing is puzzling. APOC3 program seems better than Ionis $IONS and catalyst rich 2026 on the horizon (sHTG obesity CNS etc). But all of this was already known so why is the stock up XX% today"  
[X Link](https://x.com/occams_tooth/status/1993781016897450043)  2025-11-26T20:36Z XXX followers, XXX engagements


"$150M UF for XX% co-co on a single target. The new high watermark for preclinical genetic medicine deals I think $BEAM $PFE at $100M/target was previous record holder $REGN"  
[X Link](https://x.com/occams_tooth/status/1995521002928062923)  2025-12-01T15:50Z XXX followers, XXX engagements


"I have never understood how PTCs small molecule splicing modulators can be specific for ONE snRNP at ONE exon in ONE gene in the entire genome. Seems very non-intuitive to me. Source: $PTCT R&D day"  
[X Link](https://x.com/occams_tooth/status/1996039189583069296)  2025-12-03T02:10Z XXX followers, XXX engagements


"$DNLI $RPRX is a good deal: X. $RPRX values tivi above street. $275M for X% royalty; assuming XX% margins tivi is worth $2B X. $DNLI up 7%. Good example for naysayers who say no such thing as non-dilutive financing. Thats true in theory but not for undervalued assets"  
[X Link](https://x.com/occams_tooth/status/1996937319618957713)  2025-12-05T13:38Z XXX followers, XXX engagements


"@GeneInvesting Great data and agree it seems differentiated vs $CRSP on X. Better efficacy (100% VOC free) X. Fewer days in / visits to hospital But busulfan conditioning will still limit adoption. $BEAM may well switch all Casgevy pts but hard to see a dramatic increase in class revenue"  
[X Link](https://x.com/occams_tooth/status/1997348378787655804)  2025-12-06T16:52Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@occams_tooth Avatar @occams_tooth Occam's Toothbrush

Occam's Toothbrush posts on X about $dnli, $beam, $arwr, $ions the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXX -XX%
  • X Months XXXXXXX +310%
  • X Year XXXXXXX +29,893%

Mentions: X #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX -XX%
  • X Months XXX +69%
  • X Year XXX +4,200%

Followers: XXX #

Followers Line Chart

  • X Week XXX +2.70%
  • X Month XXX +8.30%
  • X Months XXX +466%
  • X Year XXX +2,365%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence cryptocurrencies stocks

Social topic influence $dnli, $beam #33, $arwr, $ions, $150m, $pfe, target, $100mtarget, $regn, $ptct

Top accounts mentioned or mentioned by @geneinvesting @zhaoweiasu @rnaianalyst @ttramyloid @avidresearch @bertrandbio @profoak @hall8jack @theeconomist @thebiohunter @jfais20 @sanctuarybio @bowtiedbiotech @ldtimmerman @openai @zacharybrennan @jaredwhitlock @crocsanalyst @skathire @novartis

Top assets mentioned Denali Therapeutics Inc. Common Stock (DNLI) BEAM (BEAM) Arrowhead Research Corporation (ARWR) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Pfizer, Inc. (PFE) Regeneron Pharmaceuticals Inc (REGN) PTC Therapeutics, Inc. (PTCT) Royalty Pharma plc Class A Ordinary Shares (RPRX) CRISPR Therapeutics AG (CRSP)

Top Social Posts

Top posts by engagements in the last XX hours

"Tragic that $DNLI may have blundered a chance for a PRV with tivi approval. PRV sale would be over half what theyre getting in this royalty deal. $DNLI"
X Link 2025-12-05T01:31Z XXX followers, XXX engagements

"Arrowhead $ARWR stock move is logical but timing is puzzling. APOC3 program seems better than Ionis $IONS and catalyst rich 2026 on the horizon (sHTG obesity CNS etc). But all of this was already known so why is the stock up XX% today"
X Link 2025-11-26T20:36Z XXX followers, XXX engagements

"$150M UF for XX% co-co on a single target. The new high watermark for preclinical genetic medicine deals I think $BEAM $PFE at $100M/target was previous record holder $REGN"
X Link 2025-12-01T15:50Z XXX followers, XXX engagements

"I have never understood how PTCs small molecule splicing modulators can be specific for ONE snRNP at ONE exon in ONE gene in the entire genome. Seems very non-intuitive to me. Source: $PTCT R&D day"
X Link 2025-12-03T02:10Z XXX followers, XXX engagements

"$DNLI $RPRX is a good deal: X. $RPRX values tivi above street. $275M for X% royalty; assuming XX% margins tivi is worth $2B X. $DNLI up 7%. Good example for naysayers who say no such thing as non-dilutive financing. Thats true in theory but not for undervalued assets"
X Link 2025-12-05T13:38Z XXX followers, XXX engagements

"@GeneInvesting Great data and agree it seems differentiated vs $CRSP on X. Better efficacy (100% VOC free) X. Fewer days in / visits to hospital But busulfan conditioning will still limit adoption. $BEAM may well switch all Casgevy pts but hard to see a dramatic increase in class revenue"
X Link 2025-12-06T16:52Z XXX followers, XXX engagements

@occams_tooth
/creator/twitter::occams_tooth